BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14718103)

  • 1. [Treatment modalities in patients with hepatocellular carcinoma: a retrospective series in a single institution in Mexico].
    Meza-Junco J; Montaño-Loza A; Candelaria M
    Gastroenterol Hepatol; 2004 Jan; 27(1):11-7. PubMed ID: 14718103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
    Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
    Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
    Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation.
    Schumacher PA; Powell JJ; MacNeill AJ; Buczkowski AK; Erb SR; Ho SG; Scudamore CH; Steinbrecher UP; Weiss A; Yoshida E; Chung SW
    Ann Hepatol; 2010; 9(1):23-32. PubMed ID: 20308719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: a retrospective study of a 5-year experience in a single institution.
    Si Y; Hu X; Du H; Lou W; Zhang H; Cao F; Yu W; Wang W; Jin K
    Hepatogastroenterology; 2013 Sep; 60(126):1405-8. PubMed ID: 23933931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presentation, staging, and outcome of patients with hepatocellular carcinoma at a center in Veracruz, Mexico].
    Martinez-Mier G; Esquivel-Torres S; Medina Granados JP; Luna-Castillo M; Castillo-Chiquete R; Calzada-Grijalva JF; Gonzalez-Velazquez F
    Rev Gastroenterol Mex; 2014; 79(3):171-9. PubMed ID: 25236795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
    Mazzanti R; Arena U; Pantaleo P; Antonuzzo L; Cipriani G; Neri B; Giordano C; Lanini F; Marchetti S; Gentilini P
    Can J Gastroenterol; 2004 Oct; 18(10):611-8. PubMed ID: 15497001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referrals for surgical therapy in patients with hepatocellular carcinoma: a community experience.
    Helling TS; Woodall CE
    J Gastrointest Surg; 2007 Jan; 11(1):76-81. PubMed ID: 17390191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
    AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
    Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
    Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience.
    Liu CL; Fan ST; Lo CM; Tso WK; Poon RT; Lam CM; Wong J
    J Clin Oncol; 2001 Sep; 19(17):3725-32. PubMed ID: 11533094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis.
    Gournay J; Tchuenbou J; Richou C; Masliah C; Lerat F; Dupas B; Martin T; Nouel JF; Schnée M; Montigny P; D'Alincourt A; Hamy A; Paineau J; Le Néel JC; Le Borgne J; Galmiche JP
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1529-38. PubMed ID: 12182753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.